Effect of Ulinastatin on Post-operative Blood Loss and Allogeneic Transfusion in Patients Receiving Cardiac Surgery with Cardiopulmonary Bypass: a Prospective Randomized Controlled Study with 10-year Follow-up
Ulinastatin reduced post-operative blood loss and allogeneic erythrocyte transfusion in heart surgery with CPB. The mortality and major morbidity was comparable among the groups shown by the 10-year follow-up.